|
(1) Incidence and associated risks
About 20 per cent of the population is now classified
as obese. This is almost three times the figures in 1980 and the upward
trend is set to continue. The report "Tackling obesity" published last
year by the National Audit Office estimated that obesity and its related
conditions would cost the public £3.6bn by 2010. The first article
in our series on obesity explores the incidence of obesity and the risks
associated with it
(PDF 65K)
Pharmaceutical Journal, 4 May 2002, p616-618. Vol 268, no 7196 |
|
(2) Non-drug strategies
Obesity is a public health challenge. Pharmacists must
have regard to interventions that have proved most effective. This second
article in our obesity series explores the benefits of weight loss and
some of the strategies that may be employed to achieve it
(PDF 65K)
Pharmaceutical Journal, 11 May 2002, p652-654. Vol 268, no 7197 |
|
(3) Pharmacotherapy
Obesity has a substantial human cost as well as serious
financial consequences for the National Health Service. For some patients,
diet and exercise do not make enough impact on their condition. This article
looks at the treatment of obesity using drugs
(PDF 65K)
Pharmaceutical Journal, 18 May 2002, p687-689. Vol 268, no 7198 |
|
(4) How pharmacists can contribute to obesity management
This last article in our series on obesity looks at ways
in which pharmacists working in different sectors of health care can make
a difference to obesity management
(PDF 70K)
Pharmaceutical Journal, 25 May 2002, p718-720. Vol 268, no 7199 |
|
|
• Most photographs have been removed
from the PDF files for copyright reasons.
• The contents of the Pharmaceutical
Journal, associated publications and all PDF files are the
property of the Royal Pharmaceutical Society. See Copyright for
our rights. |
|
Photocopies
Photocopies of articles can be ordered from the Society’s
library (library@rpsgb.org.uk);
for details click here |
|
Reprints
Details on multiple reprints of the original articles are here |
|
Acrobat
Reader